Descriptive analysis of MS patients converting from Natalizumab (Tysabri) IV to SC formulation in Finnish register data

Descriptive analysis of MS patients converting from Natalizumab (Tysabri) IV to SC
formulation in Finnish register data.

Changes to the permit: change of processors

Issuer of the original permit: Findata